 |
|
Genes raise risk of heart disease after treatment for childhood cancer
June 05, 2006Research builds groundwork for finding personalized, less toxic cancer drugs
Gene variations may raise the risk that survivors of childhood cancer will suffer congestive heart failure as a complication of drugs they received during cancer treatment.
Richard Aplenc, M.D., a pediatric oncologist at The Children's Hospital of Philadelphia, reported on a study of childhood cancer survivors in a presentation today at the American Society of Clinical Oncology (ASCO) annual meeting in Atlanta. He led the research, drawing on data from the Childhood Cancer Survivor Study, a long-term national study sponsored by the National Cancer Institute.
The researchers studied anthracyclines, a commonly used class of anticancer drugs known to cause heart damage in some patients. The research team investigated two groups of childhood cancer survivors, all of whom had been treated with anthracyclines. The study compared 47 patients with congestive heart failure (CHF) to a control group of 195 patients without CHF.
The researchers investigated 10 polymorphisms, naturally occurring variants in DNA bases called nucleotides, in seven genes they identified as having a role in biological responses to anthracyclines. "We found that polymorphisms in the GSTP gene significantly increased a patient's risk for CHF after treatment with anthracyclines," said Dr. Aplenc. One polymorphism increased risk by five times; another variant was linked to a tripling of risk.
The research group chose particular genes as candidates for study because those genes carry the codes for enzymes involved in metabolizing anthracyclines and the reactive oxygen molecules that anthracyclines produce. If physicians can better classify gene variations that modify side effects of anticancer drugs, they may be able to better tailor treatment plans to individual patients. Thus, knowledge of a patient's genetic makeup may allow physicians to select a more personalized, less toxic treatment.
"Further study needs to be done, using larger numbers of patients, to determine if these results hold up," said Dr. Aplenc. "We hope these findings will provide a scientific foundation for safer, more effective cancer treatments for children."
Dr. Aplenc's research abstract was featured in a news conference at the ASCO meeting, which this year has a special focus on cancer survivors. Dr. Aplenc is an attending oncologist at Children's Hospital, where he researches gene variations in the enzymes that interact with chemotherapy drugs in children.
Co-authors of the study were Javier Blanco, Wendy Leisenring, Stella Davies, Mary Relling, Leslie Robison, Charles Sklar, Marilyn Stovall and Smita Bhatia.
Children's Hospital of Philadelphia
The researchers studied anthracyclines, a commonly used class of anticancer drugs known to cause heart damage in some patients. The research team investigated two groups of childhood cancer survivors, all of whom had been treated with anthracyclines. The study compared 47 patients with congestive heart failure (CHF) to a control group of 195 patients without CHF.
The researchers investigated 10 polymorphisms, naturally occurring variants in DNA bases called nucleotides, in seven genes they identified as having a role in biological responses to anthracyclines. "We found that polymorphisms in the GSTP gene significantly increased a patient's risk for CHF after treatment with anthracyclines," said Dr. Aplenc. One polymorphism increased risk by five times; another variant was linked to a tripling of risk.
The research group chose particular genes as candidates for study because those genes carry the codes for enzymes involved in metabolizing anthracyclines and the reactive oxygen molecules that anthracyclines produce. If physicians can better classify gene variations that modify side effects of anticancer drugs, they may be able to better tailor treatment plans to individual patients. Thus, knowledge of a patient's genetic makeup may allow physicians to select a more personalized, less toxic treatment.
"Further study needs to be done, using larger numbers of patients, to determine if these results hold up," said Dr. Aplenc. "We hope these findings will provide a scientific foundation for safer, more effective cancer treatments for children."
Dr. Aplenc's research abstract was featured in a news conference at the ASCO meeting, which this year has a special focus on cancer survivors. Dr. Aplenc is an attending oncologist at Children's Hospital, where he researches gene variations in the enzymes that interact with chemotherapy drugs in children.
Co-authors of the study were Javier Blanco, Wendy Leisenring, Stella Davies, Mary Relling, Leslie Robison, Charles Sklar, Marilyn Stovall and Smita Bhatia.
Children's Hospital of Philadelphia
Childhood Cancer Current Events and Childhood Cancer News RSSChildhood cancer survivors less likely to marry, Yale researchers find
Adult survivors of childhood cancer are 20 to 25 percent more likely to never marry compared with siblings and the general population, Yale School of Medicine researchers report in a new study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Brain tumors in childhood leave a lasting mark on cognition, life status
Brain tumors in childhood cast a long shadow on survivors. The first study of the lasting impact of these tumors -- the most common solid malignancies in childhood -- shows that survivors have ongoing cognitive problems.
Childhood cancer survivors experience suicidal thoughts decades after diagnosis
Adult survivors of childhood cancer have an increased risk for suicidal thoughts, even decades after their cancer treatments ended, according to a study led by Dana-Farber Cancer Institute scientists.
Survivors of childhood cancer less likely to marry
Childhood cancer survivors typically suffer from the long-term effects of cancer treatment on physical health, and results of a new study suggest that social implications also exist, which may affect their chance of an "I do" at the altar.
New treatment more than doubles survival for high risk childhood leukemia
Results of a phase two clinical trial published October 5th in the Journal of Clinical Oncology show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three-year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Studies find few risks to newborn offspring of parents who are childhood cancer survivors
Whether they can have children is one of the major concerns for adult survivors of childhood and adolescent cancer because fertility can be compromised by cancer treatment.
Scientists link genetic glitches to common childhood cancer
A multicenter team of childhood cancer researchers has discovered two genetic variations linked to an increased risk for acute lymphoblastic leukemia, or ALL, the most common childhood cancer in the United States.
Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia
Scientists at St. Jude Children's Research Hospital have identified inherited variations in two genes that account for 37 percent of childhood acute lymphoblastic leukemia (ALL), including a gene that may help predict drug response.
Cancer Mortality Rates Experience Steady Decline
The number of cancer deaths has declined steadily in the last three decades. Although younger people have experienced the steepest declines, all age groups have shown some improvement, according to a recent report in Cancer Research, a journal of the American Association for Cancer Research.
Cancer mortality rates experience steady decline
The number of cancer deaths has declined steadily in the last three decades. Although younger people have experienced the steepest declines, all age groups have shown some improvement.
More Childhood Cancer Current Events and Childhood Cancer News Articles
 |
Living With Childhood Cancer : A Practical Guide to Help Families Cope by Leigh A. Woznick (Author), Carol D. Goodheart (Author) Like a natural disaster, the diagnosis that your child has cancer can leave you and your family feeling helpless. How do you explain the disease to the child and to his or her siblings? How can you communicate your child’s needs to the hospital staff? What are the best ways to reduce the physical side effects and the emotional distress of treatment? How will you, your child or teenager, and the rest of your family cope with cancer, and what can you do to help? When and where do you find good psychological help for your child or your family? How do you manage financial and school issues? How can you foster your child’s development and self-esteem? More than 12,000 American children will be diagnosed with cancer this year, and roughly 75% will survive. In addition to excellent... |
 |
Childhood Cancer: A Handbook from St. Jude Children's Research Hospital by Scientists (Author), St. Jude Clinicians (Author), Joseph Mirro M.D. (Author), Grant Steen Ph.D. (Author), R. Grant Steen (Editor), Joseph Mirro (Editor) From clinicians and scientists at the largest children's cancer research hospital in the U.S., a guide to diagnosing, treating, and surviving childhood cancer Approximately 20,000 new cases of childhood cancer are diagnosed each year. Until now, the families who receive this devastating news have had no one volume to turn to for up-to-date information, clear answers, and authoritative resource recommendations. To meet this need, clinicians and scientists at the world-famous St. Jude Children's Research Hospital have compiled the most comprehensive and compassionate family reference available. From practical matters, such as what tests to expect during diagnosis, treatment options for each kind of cancer, and the value and availability of clinical trials, to the emotional needs of... |
 |
Celebration of Life: Musicians Against Childhood Cancer by Various Artists Recorded "live" at the annual Musicians Against Childhood Cancer bluegrass festival in Columbus, Ohio, Celebration of Life is a 2-CD set that features spirited performances by many of the top artists in bluegrass today. 136 bluegrass musicians. 37 songs. 2 CDs. 1 special reason -- to benefit St. Jude Children's Research Hospital. You can feel good knowing that 100% of the net proceeds from the sale of Celebration of Life will be donated to St. Jude Children's Research Hospital. |
 |
Cure Childhood Cancer Awareness Ribbon Magnet. by Magnet Inc. Model: M-MR-CCCA; Cure Childhood Cancer Awareness Mini Ribbon Magnet. High Quality UV protected printed vinyl ribbons backed with thick .30 mil magnetic material. Great fundraiser for awareness organizations, schools, or churches. |
 |
Childhood Cancer: A Parent's Guide to Solid Tumor Cancers, 2nd Edition by Honna Janes-Hodder (Author), Nancy Keene (Author) This second edition of the most complete parent guide available, features detailed and precise medical information about solid tumor childhood cancers, including neuroblastoma, Wilms tumor, liver tumors, soft tissue sarcomas, and bone sarcomas. In addition, it offers day-to-day practical advice on how to cope with procedures, hospitalization, family and friends, school, social and financial issues, communication, feelings, and, if therapy is not successful, the difficult issues of death and bereavement. Woven among the medical details and the practical advice are the voices of parents and children who have lived with cancer and its treatments. Parents who read this book will encounter medical facts simply explained, advice to ease their daily lives, and tools to be strong advocates for... |
 |
Clearly Charming Gold Ribbon Childhood Cancer Italian Charm by Clearly Charming Gold ribbon stands for childhood cancer awareness. It will make a great addition to your Italian charm bracelet or a perfect personalized gift. Commemorate special occasions, capture memorable moments, or simply show off your birthstone by creating your own original Italian charm bracelet. Add Clearly Charming premium quality interlocking modular Italian charm links to your Italian Charm Bracelet and create your own memory bracelet. |
|
MY HAIR'S FALLING OUT... Am I Still Pretty? A Childhood Cancer Education Video [VHS] Starring: Colleen Goddard MY HAIR'S FALLING OUT... Am I Still Pretty? A Childhood Cancer Education Video, is a fictional, one person performance which tells the story of a young girl who is diagnosed with leukemia, undergoes hospitalization and chemotherapy, and returns to school, her cancer in remission. Writer, Actress Colleen Goddard portrays all the characters in this twenty two minute program, from young cancer patient, to doctor, to family members and other kids at school and in the hospital. Although the subject matter is difficult at times - a friend she makes in the hospital dies - the program is upbeat, including animation, music and dance segments. Simple, clear information about what cancer is and how it is treated is explained, as well as insight into the feelings of patients and those who love them,... | |
 |
Cure Childhood Cancer Awareness Sweatshirt Large White by Shop Zeus |
|
Childhood Cancer Awareness Ribbon Mouse Pad by MyHeritageWear.com The Childhood Cancer Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Childhood Cancer Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Childhood Cancer Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! | |
 |
Cure Childhood Cancer Awareness Oval Decal by Magnet Inc. Model: D-OV-CCCA; Cure Childhood Cancer Awareness Oval Decal. High Quality UV protected printed vinyl material. Great fundraisers for awareness organizations, schools, churches, or your fundraiser group. Dimensions: 4 1/4" x 6 1/2" |
| © 2009 BrightSurf.com |